CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure.
暂无分享,去创建一个
M. Daly | J. Rioux | K. Kocher | A. Cohen | D. Langelier | Gilles Lapointe | A. Bitton | S. Vermeire | G. Wild | P. Paré | L. Dufresne | Josee Cousineau | A. Cohen | Diane Langelier | Kerry Kocher
[1] Judy H. Cho,et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.
[2] J. Struewing,et al. A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families , 2001, British Journal of Cancer.
[3] Jean Weissenbach,et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 , 1996, Nature.
[4] J. Terwilliger,et al. Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.
[5] S. Fisher,et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.
[6] S. P. Fodor,et al. Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21 , 2001, Science.
[7] J. Weber,et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Adami,et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. , 1991, Gastroenterology.
[9] D. Weeks,et al. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. , 2000, American journal of human genetics.
[10] A. Jeffreys,et al. High resolution analysis of haplotype diversity and meiotic crossover in the human TAP2 recombination hotspot. , 2000, Human molecular genetics.
[11] I. Leodolter. [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.
[12] L Kruglyak,et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.
[13] C. Elson. Genes, microbes, and T cells--new therapeutic targets in Crohn's disease. , 2002, The New England journal of medicine.
[14] J. Cavanaugh,et al. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. , 2001, American journal of human genetics.
[15] R Staden,et al. Automated detection of point mutations using fluorescent sequence trace subtraction. , 1998, Nucleic acids research.
[16] A. Thomson,et al. Inflammatory bowel disease in northern Alberta. An epidemiologic study. , 1988, Journal of clinical gastroenterology.
[17] S. Yamaoka,et al. Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.
[18] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[19] L. Friedman,et al. Epidemiology and the natural course of inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.
[20] P. Ross,et al. High level multiplex genotyping by MALDI-TOF mass spectrometry , 1998, Nature Biotechnology.
[21] S. Targan,et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. , 1999, Inflammatory bowel diseases.
[22] M. Daly,et al. High-resolution haplotype structure in the human genome , 2001, Nature Genetics.
[23] E S Lander,et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. , 2000, American journal of human genetics.
[24] L. Cardon,et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. , 1999, American journal of human genetics.
[25] A Wajda,et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. , 1999, American journal of epidemiology.
[26] T. Hawkins,et al. DNA purification and isolation using a solid-phase. , 1994, Nucleic acids research.
[27] Y. Ogura,et al. Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides* , 2001, The Journal of Biological Chemistry.
[28] C. O'Morain,et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. , 2002, American journal of human genetics.
[29] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[30] D. Jewell,et al. A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.
[31] Sinead B. O'Leary,et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.
[32] H. Steinhart,et al. Combination ciprofloxacin and metronidazole for active Crohn's disease. , 1998, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[33] S. Vermeire,et al. Familial and Sporadic Inflammatory Bowel Disease: Different Entities? , 2000, Inflammatory bowel diseases.